Hua et al., 1997 - Google Patents
Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancersHua et al., 1997
View HTML- Document ID
- 8867206233872394434
- Author
- Hua V
- Wang W
- Duesberg P
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
The gene-mutation-cancer hypothesis holds that mutated cellular protooncogenes, such as point-mutated proto-ras,“play a dominant part in cancer,” because they are sufficient to transform transfected mouse cell lines in vitro [Alberts, B., Bray, D., Lewis, J., Raff, M …
- 108020004532 RAS 0 title abstract description 221
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hua et al. | Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers | |
Herbarth et al. | Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease | |
Robbins et al. | Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells | |
Grimes et al. | The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death | |
Chedin et al. | The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a | |
Moore et al. | Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2 | |
Cornélis et al. | New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study | |
Scott et al. | Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer | |
Robertson et al. | In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma | |
Lee et al. | The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair | |
Sadovnikova et al. | Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy | |
Sakanaka et al. | Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription | |
Kelly et al. | A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes | |
Gualberto et al. | An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control | |
Dickens et al. | A cytoplasmic inhibitor of the JNK signal transduction pathway | |
Hanson et al. | Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development | |
Ishii et al. | The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors | |
Karas et al. | Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice | |
Timchenko et al. | Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy | |
Yoon et al. | Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53 | |
Johnson et al. | Constructing primate phylogenies from ancient retrovirus sequences | |
Murakami et al. | Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q | |
Vaira et al. | RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation | |
Tailor et al. | Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses | |
Collins et al. | Positional cloning of ZNF 217 and NABC 1: genes amplified at 20q13. 2 and overexpressed in breast carcinoma |